NCT02171546View on ClinicalTrials.gov

Relative Bioavailability of Dabigatran Etexilate Capsules With and Without Quinidine Sulfate Tablets and to Measure the Effect of Quinidine on the Absorption of Fexofenadine in Healthy Male and Female Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

January 31, 2008

Conditions
Healthy
Interventions
DRUG

Dabigatran etexilate capsules

DRUG

Quinidine sulfate tablets

DRUG

Fexofenadine tablets

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02171546 - Relative Bioavailability of Dabigatran Etexilate Capsules With and Without Quinidine Sulfate Tablets and to Measure the Effect of Quinidine on the Absorption of Fexofenadine in Healthy Male and Female Volunteers | Biotech Hunter | Biotech Hunter